Everyday Economic News

Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference

Voyager Therapeutics, Inc. announced that its Chief Executive Officer, Alfred W. Sandrock, Jr., M.D., Ph.D., will participate in a pre-recorded fireside chat at the H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference. An on-demand webcast of the chat will be available on Voyager’s investor relations website starting June 15, 2026, at 7:00 a.m. ET. Voyager is a biotechnology company focused on leveraging genetics to treat neurological diseases, with a pipeline addressing conditions like Alzheimer’s, Parkinson’s, and ALS.